STOCKHOLM, SWEDEN / ACCESS Newswire / March 21, 2025 / iZafe Group (STO:IZAFE-B) (publ) announces today that the company is changing its Certified Adviser from Mangold Fondkommission AB to Carnegie Investment Bank AB (publ).
iZafe Group AB has entered into an agreement with Carnegie Investment Bank AB regarding the role as Certified Adviser. Carnegie Investment Bank AB will assume the role of Certified Adviser on April 1, 2025. Until then, Mangold Fondkommission AB will continue to act as the company's Certified Adviser.
Contacts
Anders Segerström, Chief Executive Officer
E-mail: anders.segerstrom@izafegroup.com
Phone number: +46 70-875 14 12
iZafe Group AB (publ.)
David Bagares gata 3
111 38 Stockholm
E-mail: ir@izafegroup.com
www.izafegroup.com
eucaps.com/izafe-group
About iZafe Group AB (publ.)
iZafe Group is a Life Science company that conducts research, development and marketing of digital medical solutions and services for safer medication management at home.
The company leads the development of digital drug dispensing through the drug robot Dosell as well as the SaaS solution Pilloxa with the smart pillbox. The company's solutions reduce the risk of incorrect medication in the home, increase compliance, relieve public health care, increase the quality of life for patients and create a safer environment for relatives.
The customers consist of private individuals, pharmaceutical companies and public and private healthcare providers in Sweden, the Nordics and globally. iZafe Group primarily sells through well-established partners who already have long and deep customer relationships with the prioritized customer groups. The head office is in Stockholm.
iZafe Group AB has been listed on the Nasdaq First North Growth Market since 2018. Mangold Fondkommission AB is the company's Certified Adviser. Further information is available at www.izafegroup.com
Image Attachments
Affärer Partners
Attachments
iZafe Group AB changes Certified Adviser to Carnegie Investment Bank AB
SOURCE: iZafe Group
View the original press release on ACCESS Newswire
